These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33447592)

  • 41. Utility of high-resolution anterior segment optical coherence tomography in the diagnosis and management of sub-clinical ocular surface squamous neoplasia.
    Tran AQ; Venkateswaran N; Galor A; Karp CL
    Eye Vis (Lond); 2019; 6():27. PubMed ID: 31463333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence, treatment, and outcomes of coexistent ocular surface squamous neoplasia and pterygium.
    Oellers P; Karp CL; Sheth A; Kao AA; Abdelaziz A; Matthews JL; Dubovy SR; Galor A
    Ophthalmology; 2013 Mar; 120(3):445-450. PubMed ID: 23107578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ocular Surface Squamous Neoplasia Following Keratoplasty in Xeroderma Pigmentosa: A Series of Seven Cases.
    Vempuluru VS; Ganguly A; Kaliki S
    Curr Eye Res; 2021 Nov; 46(11):1631-1636. PubMed ID: 33908328
    [No Abstract]   [Full Text] [Related]  

  • 44. Conjunctival ultraviolet autofluorescence area decreases with age and sunglasses use.
    Lingham G; Kugelman J; Charng J; Lee SS; Yazar S; McKnight CM; Coroneo MT; Lucas RM; Brown H; Stevenson LJ; Mackey DA; Alonso-Caneiro D
    Br J Ophthalmol; 2023 May; 107(5):614-620. PubMed ID: 34815236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence.
    Cicinelli MV; Marchese A; Bandello F; Modorati G
    Ophthalmol Ther; 2018 Dec; 7(2):247-262. PubMed ID: 30030703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subconjunctival bevacizumab injection for ocular surface squamous neoplasia.
    Faramarzi A; Feizi S
    Cornea; 2013 Jul; 32(7):998-1001. PubMed ID: 23538634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ocular Surface Squamous Neoplasia With Coexistent Microbial Keratitis: Incidence, Risk Factors, Clinical Features, Microbiological Profile, and Treatment Outcome.
    Kapoor AG; Vempuluru VS; Laghimshetty S; Roy A; Sharma S; Mishra DK; Mohamed A; Kaliki S
    Cornea; 2022 Mar; 41(3):294-303. PubMed ID: 34294636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-Resolution Anterior Segment Optical Coherence Tomography in Intraepithelial Versus Invasive Ocular Surface Squamous Neoplasia.
    Singh S; Mittal R; Ghosh A; Tripathy D; Rath S
    Cornea; 2018 Oct; 37(10):1292-1298. PubMed ID: 29985794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
    Venkateswaran N; Mercado C; Galor A; Karp CL
    Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p16 Expression Correlates with Invasive Ocular Surface Squamous Neoplasms in HIV-Infected Mozambicans.
    Carrilho C; Miu C; Kim Y; Karki S; Balmaceda A; Challa B; Diamond S; Monteiro E; Marole E; Lorenzoni C; Zambujo Y; Liu YT; Schooley RT; Lin JH
    Ocul Oncol Pathol; 2020 Mar; 6(2):123-128. PubMed ID: 32258020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical interferon alpha-2b for treatment of noninvasive ocular surface squamous neoplasia with 360° limbal involvement.
    Zarei-Ghanavati S; Alizadeh R; Deng SX
    J Ophthalmic Vis Res; 2014; 9(4):423-6. PubMed ID: 25709765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ocular Surface Squamous Neoplasia: Clinicopathological Analysis and Treatment Outcome of 65 Cases.
    Hussain I; Khan BS
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):970-973. PubMed ID: 33036684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
    Kaliki S; Bejjanki KM; Desai A; Mohamed A
    Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ocular surface squamous neoplasia in HIV-infected patients: current perspectives.
    Rathi SG; Ganguly Kapoor A; Kaliki S
    HIV AIDS (Auckl); 2018; 10():33-45. PubMed ID: 29559813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic and environmental factors in conjunctival UV autofluorescence.
    Yazar S; Cuellar-Partida G; McKnight CM; Quach-Thanissorn P; Mountain JA; Coroneo MT; Pennell CE; Hewitt AW; MacGregor S; Mackey DA
    JAMA Ophthalmol; 2015 Apr; 133(4):406-12. PubMed ID: 25590795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-Resolution Optical Coherence Tomography as an Adjunctive Tool in the Diagnosis of Corneal and Conjunctival Pathology.
    Nanji AA; Sayyad FE; Galor A; Dubovy S; Karp CL
    Ocul Surf; 2015 Jul; 13(3):226-35. PubMed ID: 26045235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and Pathologic Presentation of Primary Ocular Surface Tumors among Zambians.
    Julius P; Siyumbwa SN; Moonga P; Maate F; Kaile T; Kang G; West JT; Wood C; Angeletti PC
    Ocul Oncol Pathol; 2021 Mar; 7(2):108-120. PubMed ID: 33869164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How Can We Diagnose Ocular Surface Squamous Neoplasia With Optical Coherence Tomography?
    Başkan C; Kılıcarslan A
    Cureus; 2023 Mar; 15(3):e36320. PubMed ID: 36941905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The trend of ocular surface squamous neoplasia among ocular surface tumour biopsies submitted for histology from Sekuru Kaguvi Eye Unit, Harare between 1996 and 2000.
    Pola EC; Masanganise R; Rusakaniko S
    Cent Afr J Med; 2003; 49(1-2):1-4. PubMed ID: 14562592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological Correlates of Ocular Surface Squamous Neoplasia.
    Kalas T; Vagenas D; Maccheron L; Toalster N
    Ocul Oncol Pathol; 2024 Jun; 10(2):88-97. PubMed ID: 38882020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.